1. U.S. Military Forces Deployed in 70 Percent of World’s Nations
The covert exercise of U.S. military power is a recurrent subject of Project Censored stories. This year’s top censored story joins that long tradition. It deals with the massive expansion in the number of countries where the officially unnamed war on terror is now being waged by U.S. Special Operations Forces—147 of the world’s 195 recognized nations, an 80 percent increase since 2010. This includes a dramatic expansion in Africa.
The majority of the activity is in “training missions,” meaning that this expansion is promoting a coordinated worldwide intensification of conflict, unseen at home, but felt all around the globe. Writing for TomDispatch, the Nation and the Intercept, Nick Turse exposed different aspects of this story and its implications.
Turse’s story for the Intercept focused on the development of a single base, Chabelley Airfield, in the East African nation of Djibouti. It’s an “out-of-the-way outpost” transformed into “a key hub for its secret war…in Africa and the Middle East.”
In the Nation, Turse tackled the question of mission success. Project Censored noted that, “Turse [had] reported skepticism from a number of experts in response to this question, pointing out that 'impacts are not the same as successes.'”
In Vietnam, body counts were mistaken for signs of success.
“Today, tallying up the number of countries in which Special Operations forces are present repeats this error,” Vietnam veteran and author Andrew Bacevich told Turse.
2. Crisis in Evidence-Based Medicine
The role of science in improving human health has been one of humanity’s greatest achievements, but the profit-oriented influence of the pharmaceutical industry has created a crisis situation. That research simply cannot be trusted. Burying truth for profit is a recurrent theme for Project Censored. The top 1981 story concerned fraudulent testing from a single lab responsible for one-third of the toxicity and cancer testing of chemicals in America. But this problem is much more profound.
“Something has gone fundamentally wrong” said Richard Horton, editor of the Lancet, commenting on a UK symposium on the reproducibility and reliability of biomedical research:
"[M]uch of the scientific literature, perhaps half, may simply be untrue. Afflicted by studies with small sample sizes, tiny effects, invalid exploratory analyses, and flagrant conflicts of interest, together with an obsession for pursuing fashionable trends of dubious importance, science has taken a turn towards darkness. . . The apparent endemicity of bad research behaviour is alarming."
Horton’s conclusion echoed Marcia Angell, a former editor of the New England Journal of Medicine, who went public in 2009.
A classic case was Study 329 in 2001, which reported that paroxetine (Paxil in the United States/Seroxat in the United Kingdom) was safe and effective for treating depressed children and adolescents, leading doctors to prescribe Paxil to more than 2 million U.S. children and adolescents by the end of 2002, before being called into question. The company responsible (now GlaxoSmithKline), agreed to pay $3 billion in 2012, the “largest healthcare fraud settlement in U.S. history,” according to the U.S. Department of Justice.
Nonetheless, the study has not been retracted or corrected, and “none of the authors have been disciplined,” Project Censored points out. This, despite a major reanalysis which “‘starkly’ contradicted the original report’s claims.” The reanalysis was seen as the first major success of a new open data initiative known as Restoring Invisible and Abandoned Trials.
While Project Censored noted one Washington Post story on the reanalysis, there was only passing mention of the open data movement. “Otherwise, the corporate press ignored the reassessment of the paroxetine study,” and beyond that, “Richard Horton’s Lancet editorial received no coverage in the U.S. corporate press.”
Subscribe now to get the latest news delivered right to your inbox.